Kristen K. Buck
EVP, R&D and CMO · LISATA THERAPEUTICS, INC.
Individual
- 2024
- Oct 2, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Kristen K. Buck's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- WARBURG PINCUS CO. - $1.12B in SHC purchases and sales in the last 12 months
- CP Circle ML Holdco GP, LLC - $1.07B in MDLN purchases and sales in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
- Martine A. Rothblatt - $801.69M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kristen K. Buck?
Kristen K. Buck is a corporate insider, tracked as EVP, R&D and CMO of LISATA THERAPEUTICS, INC. (LSTA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kristen K. Buck last file a Form 4?
The only primary Form 4 on record is dated 2 October 2024.
